Covered recipient · General Payments record
MATTHEW D WILLIAMS
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$1,665.15
- Reported across 44 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $582.81 | 16 |
| Education | $99.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $243.79 | 5 |
| AVEO Pharmaceuticals, Inc. | $122.40 | 2 |
| E.R. Squibb & Sons, L.L.C. | $100.00 | 1 |
| Acerta Pharma LLC | $56.08 | 1 |
| Merck Sharp & Dohme Corporation | $35.24 | 2 |
| Tempus AI, Inc | $29.98 | 1 |
| PFIZER INC. | $24.12 | 1 |
| Janssen Biotech, Inc. | $20.45 | 1 |
| EISAI INC. | $18.28 | 1 |
| Incyte Corporation | $16.87 | 1 |
| GlaxoSmithKline, LLC. | $14.60 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $56.08 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104409847 | CMS |
| Aveo Pharmaceuticals, Inc. | $99.00 | 04/15/2024 | Education | Undisputed | 01/23/2026 | 1143496728 | CMS |
| Aveo Pharmaceuticals, Inc. | $23.40 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143496734 | CMS |
| E.R. Squibb & Sons, L.L.C. | $100.00 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101359790 | CMS |
| Eisai Inc. | $18.28 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110814254 | CMS |
| GlaxoSmithKline, LLC. | $14.60 | 01/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116434632 | CMS |
| Incyte Corporation | $16.87 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141274514 | CMS |
| Janssen Biotech, Inc. | $20.45 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078374729 | CMS |
| Lilly USA, LLC | $16.84 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135810497 | CMS |
| Lilly USA, LLC | $101.14 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135840711 | CMS |
| Lilly USA, LLC | $14.43 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135810499 | CMS |
| Lilly USA, LLC | $105.44 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135818660 | CMS |
| Lilly USA, LLC | $5.94 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135756550 | CMS |
| Merck Sharp & Dohme LLC | $17.01 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141850408 | CMS |
| Merck Sharp & Dohme LLC | $18.23 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141636147 | CMS |
| PFIZER INC. | $24.12 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131302415 | CMS |
| Tempus AI, Inc | $29.98 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150188750 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.